SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
AHMED NADIM

(Last) (First) (Middle)
C/O CELGENE CORPORATION
86 MORRIS AVENUE

(Street)
SUMMIT NJ 07901

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/13/2018
3. Issuer Name and Ticker or Trading Symbol
CELGENE CORP /DE/ [ CELG ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Pres., Hematology and Oncology
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 10,038 D
Common Stock 1,862 I 401(k) Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (1)(2) 01/30/2022 Common Stock 1,750 $36.36 D
Stock Option (right to buy) (1)(2) 04/30/2022 Common Stock 5,624 $36.47 D
Stock Option (right to buy) (1)(2) 10/31/2022 Common Stock 5,626 $36.68 D
Stock Option (right to buy) (1)(2) 12/17/2022 Common Stock 9,000 $40.22 D
Stock Option (right to buy) (1)(2) 01/28/2023 Common Stock 1,408 $49.48 D
Stock Option (right to buy) (1)(2) 01/28/2023 Common Stock 4,218 $49.48 D
Stock Option (right to buy) (1)(2) 04/29/2023 Common Stock 3,238 $59.24 D
Stock Option (right to buy) (1)(2) 04/29/2023 Common Stock 512 $59.24 D
Stock Option (right to buy) (1)(2) 07/29/2023 Common Stock 3,750 $71.33 D
Stock Option (right to buy) (1)(2) 10/28/2023 Common Stock 3,750 $78.12 D
Stock Option (right to buy) (1)(2) 12/02/2023 Common Stock 4,000 $81.56 D
Stock Option (right to buy) (1)(2) 02/03/2024 Common Stock 2,812 $74.3 D
Stock Option (right to buy) (1)(2) 02/03/2024 Common Stock 938 $74.3 D
Stock Option (right to buy) (2)(3) 07/28/2024 Common Stock 7,155 $87.64 D
Stock Option (right to buy) (2)(4) 07/28/2024 Common Stock 345 $84.64 D
Stock Option (right to buy) (2)(5) 10/27/2024 Common stock 3,750 $103.1 D
Stock Option (right to buy) (2)(6) 12/19/2024 Common Stock 5,000 $117.18 D
Stock Option (right to buy) (2)(7) 02/02/2025 Common Stock 2,907 $118.57 D
Stock Option (right to buy) (2)(8) 02/02/2025 Common Stock 843 $118.57 D
Stock Option (right to buy) (2)(9) 05/04/2025 Common Stock 5,000 $109.9 D
Stock Option (right to buy) (2)(10) 07/27/2025 Common Stock 5,000 $132.56 D
Stock Option (right to buy) (2)(11) 11/09/2025 Common Stock 5,000 $114.08 D
Stock Option (right to buy) (2)(12) 02/01/2026 Common Stock 4,008 $100.8 D
Stock Option (right to buy) (2)(13) 02/01/2026 Common Stock 992 $100.8 D
Stock Option (right to buy) (2)(14) 05/02/2026 Common Stock 3,125 $104.97 D
Explanation of Responses:
1. The option is immediately exercisable and fully vested.
2. The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
3. The option is immediately exercisable and will vest as follows: 1,875 shares on July 28, 2015 (VESTED); 1,875 shares on July 28, 2016 (VESTED); 1,875 shares on July 28, 2017 (VESTED); and 1,530 shares on July 28, 2018.
4. The option is immediately exercisable and will fully vest on July 28, 2018.
5. The option is immediately exercisable and will vest as follows: 937 shares on October 27, 2015 (VESTED); 937 shares on October 27, 2016 (VESTED); 938 shares on October 27, 2017 (VESTED); and 938 shares on October 27, 2018.
6. The option is immediately exercisable and will vest as follows: 1,250 shares on December 19, 2015 (VESTED); 1,250 shares on December 19, 2016 (VESTED); 1,250 shares on December 19, 2017 (VESTED); and 1,250 shares on December 19, 2018.
7. The option is immediately exercisable and will vest as follows: 937 shares on February 2, 2016 (VESTED); 937 shares on February 2, 2017 (VESTED); 937 shares on February 2, 2018 (VESTED); and 95 shares on February 2, 2019.
8. The option is immediately exercisable and will fully vest on February 2, 2019.
9. The option is immediately exercisable and will vest as follows: 1,250 shares on May 4, 2016 (VESTED); 1,250 shares on May 4, 2017 (VESTED); 1,250 shares on May 4, 2018 (VESTED); and 1,250 shares on May 4, 2019.
10. The option is immediately exercisable and will vest as follows: 1,250 shares on July 27, 2016 (VESTED); 1,250 shares on July 27, 2017 (VESTED); 1,250 shares on July 27, 2018; and 1,250 shares on July 27, 2019.
11. The option is immediately exercisable and will vest as follows: 1,250 shares on November 9, 2016 (VESTED); 1,250 shares on November 9, 2017 (VESTED); 1,250 shares on November 9, 2018; and 1,250 shares on November 9, 2019.
12. The option is immediately exercisable and will vest as follows: 1,250 shares on February 1, 2017 (VESTED); 1,250 shares on February 1, 2018 (VESTED); 1,250 shares on February 1, 2019; and 258 shares on February 1, 2020.
13. The option is immediately exercisable and will fully vest on February 1, 2020.
14. The option is immediately exercisable and will vest as follows: 781 shares on May 2, 2017 (VESTED); 781 shares on May 2, 2018 (VESTED); 781 shares on May 2, 2019; and 782 shares on May 2, 2020.
/s/ Nadim Ahmed 06/13/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.